RE: Time and again24 Jan 2019 08:11
Ruck absolutely.
Individual pronouncements on how good the science is will have no effect whatsoever on the SP in a meaningful way unless they are independent,expert and backed up by a commercial deal of some sort.
You need data for pharma to make a move and is as simple as that.
Great data and massive re valuation.
Moderate data and I mean in humans not mice for Moditope for efficacy and safety and the road ahead will be tough.
For the record I am confident the data will be good enough hence I am heavily invested here but there is risk